Search Results - "Spiers, JP"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases by Rietz, A, Spiers, JP

    Published in British journal of pharmacology (01-06-2012)
    “…The MMPs and their inhibitors [tissue inhibitor of MMPs (TIMPs) ] form the mainstay of extracellular matrix homeostasis. They are expressed in response to…”
    Get full text
    Journal Article
  2. 2

    Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events by Svärd, J, Blanco, F, Nevin, D, Fayne, D, Mulcahy, F, Hennessy, M, Spiers, J P

    Published in British journal of pharmacology (01-01-2014)
    “…Background and Purpose Antiretroviral (ARV) drugs activate pregnane X receptors and constitutive androstane receptors, increasing the risk of drug interactions…”
    Get full text
    Journal Article
  3. 3

    St John's Wort increases expression of P‐glycoprotein: Implications for drug interactions by Hennessy, M., Kelleher, D., Spiers, J. P., Barry, M., Kavanagh, P., Back, D., Mulcahy, F., Feely, J.

    Published in British journal of clinical pharmacology (01-01-2002)
    “…Aims  St John's Wort (SJW) is widely used in the treatment of depression but concerns have been raised about its potential to interact with other drugs…”
    Get full text
    Journal Article
  4. 4

    Okadaic acid induces matrix metalloproteinase-9 expression in fibroblasts: crosstalk between protein phosphatase inhibition and [beta]-adrenoceptor signalling by Rietz, A, Volkov, Y, Davies, A, Hennessy, M, Spiers, JP

    Published in British journal of pharmacology (01-01-2012)
    “…BACKGROUND AND PURPOSE Interactions between protein phosphatase inhibition and matrix metalloproteinase (MMP)-9 expression have implications for tissue…”
    Get full text
    Journal Article
  5. 5

    Okadaic acid induces matrix metalloproteinase‐9 expression in fibroblasts: crosstalk between protein phosphatase inhibition and β‐adrenoceptor signalling by Rietz, A, Volkov, Y, Davies, A, Hennessy, M, Spiers, JP

    Published in British journal of pharmacology (01-01-2012)
    “…BACKGROUND AND PURPOSE Interactions between protein phosphatase inhibition and matrix metalloproteinase (MMP)‐9 expression have implications for tissue…”
    Get full text
    Journal Article
  6. 6

    Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension : effects of endothelin receptor blockade by SPIERS, James P, KELSO, Elizabeth J, SIAH, Wei F, EDGE, Gillian, GUOJIE SONG, MCDERMOTT, Barbara J, HENNESSY, Martina

    Published in Journal of hypertension (01-09-2005)
    “…To determine the effects of age and dual endothelin (ET)A/ETB receptor antagonism (bosentan) on aortic matrix metalloproteinase (MMP) abundance and tissue…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Intracellular accumulation of nelfinavir and its relationship to P-glycoprotein expression and function in HIV-infected patients by HENNESSY, Martina, CLARKE, Susan, SPIERS, J. Paul, KELLEHER, Dermot, MULCAHY, Fiona, HOGGARD, Patrick, BACK, David, BARRY, Michael

    Published in Antiviral therapy (01-02-2004)
    “…To compare plasma and intracellular nelfinavir pharmacokinetics, and determine their relationship to P-glycoprotein (P-gp) expression and function in…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Endothelin(A) receptor subtype mediates endothelin-induced contractility in left ventricular cardiomyocytes isolated from rabbit myocardium by Kelso, E J, McDermott, B J, Silke, B, Spiers, J P

    “…Endothelin (ET)-1 is a potent positive inotropic agent, the effects of which are mediated by increases in cytosolic Ca(2+) in the myocardium. The object of…”
    Get more information
    Journal Article
  11. 11

    Intracellular indinavir pharmacokinetics in HIV-infected patients: comparison with plasma pharmacokinetics by HENNESSY, Martina, CLARKE, Susan, HAGGARD, Patrick, BACK, David, BARRY, Michael, SPIERS, J. Paul, MULCAHY, Fiona, KELLEHER, Dermot, MEADON, Emma, MAHER, Bridget, BERGIN, Colm, KHOO, Saye, TJIA, John

    Published in Antiviral therapy (01-06-2003)
    “…To determine intracellular concentrations of indinavir (IDV) and investigate the relationship between plasma and intracellular IDV pharmacokinetics in…”
    Get full text
    Journal Article
  12. 12

    Inotropic response to endothelin‐1, isoprenaline and calcium in cardiomyocytes isolated from endotoxin treated rats: effects of ethyl‐isothiourea and dexamethasone by Spiers, J P, Kelso, E J, Allen, J D, Silke, B, McDermott, B J

    Published in British journal of pharmacology (01-07-2000)
    “…The contractile effects of endothelin‐1, isoprenaline and extracellular calcium were assessed on ventricular cardiomyocytes isolated from…”
    Get full text
    Journal Article
  13. 13

    Myocardial Expression of the Endothelin System in Endotoxin- Treated Rats by Spiers, James Paul, Dorman, Alastair, Allen, John Desmond, Kelso, Elizabeth Jane, Silke, Bernard, McDermott, Barbara Jean

    Published in Journal of cardiovascular pharmacology (01-08-2001)
    “…Although circulating plasma levels of endothelin (ET)-1 are elevated in endotoxemia, little is known about the myocardial expression of the ET system in…”
    Get full text
    Journal Article
  14. 14

    Receptor-mediated effects of endothelin on the L-type Ca++ current in ventricular cardiomyocytes by Kelso, E J, Spiers, J P, McDermott, B J, Scholfield, C N, Silke, B

    “…The purpose of this study was to establish whether specific receptor subtypes are responsible for mediating the effects of endothelin-1 (ET-1) and endothelin-3…”
    Get more information
    Journal Article
  15. 15

    Stimulation of L-type Ca2+ current by the endothelin receptor A-selective antagonist, BQ-123, in ventricular cardiomyocytes isolated from rabbit myocardium by KELSO, E. J, SPIERS, J. P, MCDERMOTT, B. J, SCHOLFIELD, C. N, SILKE, B

    Published in Biochemical pharmacology (15-03-1998)
    “…BQ-123 is extensively used as an antagonist at endothelin (ET) receptors, having selectivity at the ET(A) receptor subtype. In this study, the effects of…”
    Get full text
    Journal Article
  16. 16

    Endothelin‐1 mediated inhibition of the acetylcholine‐activated potassium current from rabbit isolated atrial cardiomyocytes by Spiers, J. Paul, Kelso, Elizabeth J., McDermott, Barbara J., Scholfield, C. Norman, Silke, Bernard

    Published in British journal of pharmacology (01-12-1996)
    “…1 Endothelin‐1 is a 21 amino acid peptide with potent inotropic and chronotropic actions in the heart. Relatively little is known about the underlying…”
    Get full text
    Journal Article
  17. 17

    Acute and chronic effects of rilmenidine on baroreflex function in conscious dogs by Spiers, J P, Harron, D W, Wilson, R

    Published in European journal of pharmacology (08-06-1990)
    “…The effects of acute and chronic administration of rilmenidine on blood pressure, heart rate and baroreflex function were assessed in two groups of six…”
    Get more information
    Journal Article
  18. 18

    UK-52,046 (a novel alpha 1-adrenoceptor antagonist) and the role of alpha-adrenoceptor stimulation and blockade on atrioventricular conduction by Spiers, J P, Harron, D W, Wilson, R, Allen, J D

    Published in Journal of cardiovascular pharmacology (01-11-1990)
    “…The effects of increasing intravenous (i.v.) doses of prazosin, phenylephrine, flecainide, and UK-52,046 on blood pressure (BP), heart rate (HR) and the…”
    Get more information
    Journal Article
  19. 19

    Resuscitation of hemorrhagic shock with hypertonic saline/dextran or lactated Ringer's supplemented with AICA riboside by Spiers, J P, Fabian, T C, Kudsk, K A, Proctor, K G

    Published in Circulatory shock (01-05-1993)
    “…Anesthetized and ventilated swine were bled 23 ml/kg (34% of calculated blood volume) to a mean arterial pressure < 50 mm Hg. After 60 min, a bolus of either…”
    Get more information
    Journal Article